This discussion reviews neoadjuvant chemoimmunotherapy outcomes in stage III non-small cell lung cancer, suggesting improved treatment responses.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Garbo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: